Filing Details
- Accession Number:
- 0000899243-20-030860
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-12 17:54:39
- Reporting Period:
- 2020-11-09
- Accepted Time:
- 2020-11-12 17:54:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1805387 | Cerevel Therapeutics Holdings Inc. | CERE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578965 | Adam Koppel | C/O Bain Capital Life Sciences Investors 200 Clarendon Street Boston MA 02116 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-09 | 332,293 | $10.30 | 60,632,356 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Footnotes
- On November 9, 2020, BC Perception Holdings, LP ("BC Perception") purchased 332,293 shares of the Issuer's Common Stock at a price of $10.30 per share.
- Adam Koppel is a Managing Director of Bain Capital Life Sciences Investors, LLC, which is the ultimate general partner of Bain Capital Life Sciences Fund, LP. As a result, Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC Perception. Dr. Koppel disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
